10x Genomics, Inc. - CL A COM (TXG)

Historical Portfolio Holders from Q3 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / CL A COM
Shares, excl. options Q2 2024
105M
Holdings value Q2 2024
$2.05B
Value change Q2 2024
+$24.9M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
253
Number of buys Q2 2024
67
Number of sells Q2 2024
-52
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 26.5M $598M -$19.2M $22.58 95
2024 Q2 105M $2.05B +$24.9M $19.45 253
2024 Q1 102M $3.83B +$179M $37.53 279
2023 Q4 95.9M $5.37B +$218M $55.96 266
2023 Q3 90.5M $3.73B +$45.9M $41.25 250
2023 Q2 89.1M $4.97B -$57.7M $55.84 269
2023 Q1 90.1M $5.02B +$211M $55.79 254
2022 Q4 87.5M $3.19B +$104M $36.44 251
2022 Q3 86M $2.45B -$43.8M $28.48 205
2022 Q2 86M $3.91B +$82.7M $45.25 225
2022 Q1 82.7M $6.29B -$75.6M $76.07 289
2021 Q4 79.8M $11.9B +$63.8M $148.96 347
2021 Q3 78.8M $11.5B +$128M $145.58 318
2021 Q2 77.9M $15.2B +$1.52B $195.82 334
2021 Q1 70.5M $12.8B +$832M $181.00 311
2020 Q4 66.2M $9.38B -$750M $141.60 300
2020 Q3 69.1M $8.55B +$1.07B $124.68 218
2020 Q2 61M $5.45B +$1.16B $89.31 143
2020 Q1 38.9M $2.43B +$613M $62.32 104
2019 Q4 30.8M $2.35B +$109M $76.25 86
2019 Q3 22.3M $1.13B +$1.13B $50.40 92